These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17366674)

  • 41. Sildenafil citrate improves erectile function: a randomised double-blind trial with open-label extension.
    McVary KT; Kaufman J; Young JM; Tseng LJ
    Int J Clin Pract; 2007 Nov; 61(11):1843-9. PubMed ID: 17887993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
    Giammusso B; Colpi GM; Cormio L; Ludovico G; Soli M; Ponchietti R; Montorsi F; Panzironi C; Guastella B
    Urol Int; 2008; 81(4):409-15. PubMed ID: 19077401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Listerine's long shadow: disease mongering and the selling of sickness.
    Dossey L
    Explore (NY); 2006; 2(5):379-85. PubMed ID: 16979097
    [No Abstract]   [Full Text] [Related]  

  • 44. Sildenafil citrate in the treatment of sexual dysfunction and its effect on quality of life in alcohol dependent men: preliminary findings.
    Grinshpoon A; Margolis A; Weizman A; Ponizovsky AM
    Alcohol Alcohol; 2007; 42(4):340-6. PubMed ID: 17537832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sildenafil reduces bother associated with erectile dysfunction: pooled analysis of five randomized, double-blind trials.
    Seftel AD; Creanga DL; Levinson IP
    Int J Impot Res; 2007; 19(6):584-90. PubMed ID: 17611607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depression and erectile dysfunction.
    Makhlouf A; Kparker A; Niederberger CS
    Urol Clin North Am; 2007 Nov; 34(4):565-74, vii. PubMed ID: 17983896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of formulary replacement of sildenafil by vardenafil at a local VA hospital.
    Singh M; Seftel AD
    Int J Impot Res; 2008; 20(2):188-91. PubMed ID: 17805337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Move over, Viagra.
    Gupta S
    Time; 2003 Sep; 162(9):66. PubMed ID: 12964401
    [No Abstract]   [Full Text] [Related]  

  • 50. Sildenafil citrate efficacy 8 h postdose in men with mild to moderate erectile dysfunction.
    McCullough AR; Steidle CP; Kaufman J; Goldfischer ER; Klee B; Carlsson M
    Int J Impot Res; 2008; 20(4):388-95. PubMed ID: 18528401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In that case.
    Elkin S
    J Bioeth Inq; 2005; 2(3):179. PubMed ID: 16578944
    [No Abstract]   [Full Text] [Related]  

  • 52. Is sildenafil citrate associated with an amelioration of the symptomatology of androgen decline in the aging male?
    Koulikov D; Fridmans A; Chertin B; Shenfeld O; Farkas A; Spitz IM
    J Urol; 2007 Jun; 177(6):2267-71. PubMed ID: 17509338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct-to-consumer advertising for erectile dysfunction drugs.
    Karlowicz KA
    Urol Nurs; 2009; 29(4):214. PubMed ID: 19718935
    [No Abstract]   [Full Text] [Related]  

  • 54. Ethical implications of drugs for erectile dysfunction.
    Caplan A
    Virtual Mentor; 2014 Nov; 16(11):928-31. PubMed ID: 25397654
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
    Ahn TY; Lee SW; Kim SW; Yang DY; Park NC; Min KS; Park K; Paick JS; Dyachkova Y; Dwight T; Lee MS
    Asian J Androl; 2007 Nov; 9(6):760-70. PubMed ID: 17968461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized, double-blind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: efficacy at 8 and 12 hours postdose.
    McCullough AR; Steidle CP; Klee B; Tseng LJ
    Urology; 2008 Apr; 71(4):686-92. PubMed ID: 18387397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [La Peyronie disease, erectile dysfunction, kidney tumors]].
    Beley S
    Prog Urol; 2008 Feb; 18(1 Suppl FMC):F32-4. PubMed ID: 18773852
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
    Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
    BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors predicting successful response to sildenafil after radical cystoprostatectomy.
    El-Bahnasawy MS; Ismail T; Elsobky E; Alzalouey EI; Bazeed MA
    Scand J Urol Nephrol; 2008; 42(2):110-5. PubMed ID: 17853038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Viagra, Parkinson, AIDS and circumcision].
    Nau JY
    Rev Med Suisse; 2009 Dec; 5(230):2588-9. PubMed ID: 20088083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.